Pathways to Impact

Using Pathways to Impact and Commercial Roadmapping to Increase your Academic Success

 
 

Have you ever felt that:

  • Getting your technology to market seems impossible
  • Getting your new treatments to patients have insurmountable barriers
  • Others increase their success through Pathways to Impact and not you
  • Your grants are being turned down because your forecasts of the future market are unrealistic
  • You are dreading the 2021 Research Excellence Framework

If so Ortheia can help you

 
Ortheia-frustration.jpg

And

Our new service could cost you nothing*


Our Three-Stage Service

Stage 1: Grant Application** 

In this Stage we will help you to:

  • Define the Key Areas of Impact
  • Define realistic and clear objectives
  • Detail project activities that will generate the impact
  • Describe how impact activities will be managed to maximise impact
  • Give evidence of ability to achieve those objectives

**Note: We don't write your grants for you, but our support will help you write grants in which you can have confidence.

At the time of writing (July 2017) the Ortheia Team's grant success rate is 86%

Stage 2: Project Delivery

In this Stage we will deliver with and for you:

  • Reports on workshops with all stakeholders
  • Roadmaps detailing the route to clinic and to market
  • Timescales for all stages to the use clinic and market launch
  • Detailed costs of all future stages
  • Maps of the regulatory processes for all major world markets
  • List of all major risks and how they will be mitigated fully
  • Realistic analyses of the targeted markets
  • Valuation of the current value of the technology
  • 'Pathway to Impact' report

We will deliver all these in a format that fits in with your final report, which we will help you write

Stage 3: To Launch and the Clinic

Our greatest strength though comes into play after your grant-funded project has been completed. Ortheia's skills, expertise and processes will support you to increase dramatically the chance of success of your new technology getting to treat patients and getting to market.

We can help you:

  • Get regulatory approval for all major markets
  • Get that illusive investment
  • Run clinical trials
  • Manufacture your devices using fully-validated processes
  • Access the major world markets
  • Launch the products globally

Ortheia's New 'No-Win-No-Fee' Service*

In July 2017 Ortheia launched an exciting new service that can allow you to access these services at no cost to yourself.

We will wave all our fees for the "Stage 1: Grant Application" work that we will do with you, if we have successfully been awarded the project that includes a work package that will pay Ortheia to complete its work in "Stage 2: Project Delivery", which will be paid for by the grant-giving body. For Research Councils this is normally subcontracted to us.


*Note: Our 'No-Win-No-Fee' Service is subject to our Terms and Conditions, which you can get by contacting us here or emailing us at Contact@Ortheia.com


 

See our flyer for more information

 

Or

If you want us to tell you more about our Pathways to Impact Service please contact us here


Testimonials

I have worked on roadmaps before and - while useful as a means of thinking ahead - they often seemed highly speculative and I questioned their real value as strategic tools. Bringing my team together with Ortheia’s was a very different experience, not only did we take the time to really dig into each subject, the breadth of experience present provided very real insights into the path and investment needed to take a promising technology to the market.
— Paul Hatton, University of Sheffield

The workshop was a great communicative experience bringing together the thoughts of academics, and all involved to agree on the first embodiment of the technology taking account of the market drivers, as well as the economic environment and needs of the stakeholders.

The risks and mitigation measures, and ancillary opportunities for the future were all mapped out resulting in a detailed plan with a timeline of the steps and milestones towards realising our goals.

Having undertaken this workshop, we now have a realistic route towards commercialisation in which all involved can have confidence in its success.
— Wayne Austin, Ceramisys Ltd.

At the concept stage there are many uncertainties surround the commercial viability of a new medical device. Mistakes or foresight in the earlier phases of product development tend to be amplified over the course of a project. Therefore, having a rigorous approach and supporting tools to identify and filter a development portfolio at the early stages can be highly rewarding.

The JRI Orthopaedics Roadmapping Exercise provides a powerful analytical tool, leveraging decades of med-tech business and product development expertise. Applied in an inclusive environment, their Workshop aims to understand and accelerate delivery of the strategic vision, development processes, investment needs, risk/return analysis and ultimately a NPV (Net Present Value) of the new technology opportunity.

The model is built upon a simplified stage-gated framework from which the value of a new medical device can be extracted at its concept stage and is intended to complement existing proposals for the evaluation of the commercial headroom available to new medical products.
— Dr Mark Gostock, Senior Business Manager UCL Business PLC